Synthetic Biology Solutions

Share
Tsingke offers comprehensive nucleic acid synthesis solutions, including 12 to 384-channel synthesizers, synthesis levels from pmol to umol, and synthesis volumes from micrograms to milligrams. Our professional synthesis instruments and complementary reagents, ensuring a complete solution for your nucleic acid synthesis needs.
01
Equipment
Tsingke has independently developed a range of synthesizers tailored for various synthesis scales and throughput needs in synthetic biology. Here’s an overview of our synthesizer lineup and supporting equipment:
Single-Stranded Nucleic Acid Synthesizers:Syn-HCY-12P, 24P,192P/B, 768B
- High-capacity Synthesizer: 5mmol (flip), 50mmol (10 pumps), 192P-G2, mini, 50mmol, 12mmol
- High-quality Synthesizer: 384B-G2, 12P-M, 96P-M
- Supporting Equipment: Ammonolyzer, Dissolver, Nucleic Acid Purifier, Nucleic Acid Dispenser
These instruments work together to offer a comprehensive, reliable, and cost-effective solution, delivering high-quality and efficient synthetic products to researchers for diverse applications in synthetic biology.
02
Chemical Reagents
Tsingke has developed the DNAchem solvent and reagent series, produced through a rigorous synthesis and purification process to meet strict technical specifications. This product line is designed to offer excellent synthesis efficiency, making it an ideal choice for oligonucleotide synthesis. DNAchem Product Lineup:
- Deprotecting Agents
- Activators
- Capping Reagents
- Oxidizing Agents
- Acetonitrile (with extremely low water content)
DNAchem solvents and reagents are designed for use in applications such as pharmacogenomics, diagnostic methods, and drug development. They are widely utilized in both laboratory settings and large-scale DNA/RNA synthesis production. Available in a variety of packaging sizes (from 100 mL glass bottles to 200L large containers), catering to the needs of a broad range of users.
03
Synthetic Columns
Tsingke specializes in the research and development of synthetic columns, which are key to advancing oligo synthesis.
- First-Generation Synthetic Columns (2008)
- The second-generation synthesis columns were developed, which greatly improved the purity of Oligo, reduced the mutation rate, and improved the cost controllability of related synthetic biology research.
04
Bioreagents
Tsingke has successfully established a comprehensive network of bioreagents. Here’s an overview of our product lineup:
- Cloning Series
- Competent Cell Series
- Nucleic Acid Purification Series
- Reverse Transcription Series
- qPCR Series
- PCR Series
- Magnetic Bead Series
Focusing on rapid cloning and construction, Tsingke aims to leverage advanced rapid cloning technologies to provide fast, efficient, and comprehensive cloning construction products and services. These solutions are designed to make scientific research simpler, more efficient, intelligent, and secure.
Why Choose Tsingke
We operate synthesis laboratories with 24-hour delivery in over twenty cities, catering to the synthetic requirements of research and corporate users, leading to a wealth of synthesis experience. This informs continuous adjustments and upgrades to our synthesizers, aligning with market demands and customer feedback, thereby improving the precision and user-friendliness of our instruments.

Concurrently, our gene synthesis, sequencing, and project departments consistently employ in-house developed molecular reagents for fundamental molecular experiments. The development and enhancement of all our products are grounded in our firsthand usage experience.
Decades of Accumulated Experience
Robust Technical Team
Continuous Product Upgrades
Numerous Production Validations
Got A Question?
Got A Question?
If you have any questions or need assistance, please feel free to reach out at any time. Our dedicated team is ready to help and provide the support you need!
pop_close
pop_main
Subscribe to Our Newsletter
Stay updated with the latest industry news and expert insights. Subscribe now to receive:
        ● Industry updates
        ● Exclusive expert insights and analysis
Enter your email to stay ahead!